Strategic CDMO Novex is a full-spectrum contract development and manufacturing organization with capabilities spanning formulation, tissue processing, biologics, regulatory support, and scale-up across clinical to commercial stages, presenting multiple cross-sell opportunities to clients seeking integrated manufacturing partnerships.

Regulatory Readiness With cGMP operations, ISO 13485 monitoring, FDA registration, and capabilities for regulatory support, Novex can be positioned to sell end-to-end compliance and documentation services to firms aiming to accelerate approval timelines and reduce regulatory risk.

Capacity & Scale Recent asset investments and expansion in large-scale facilities, plus ongoing scale-up manufacturing expertise, suggest opportunities to upsell additional capacity, accelerated timelines, and long-term manufacturing commitments for growing regenerative medicine and biologics programs.

Strategic Partnerships Partnerships with FetTech and collaborations with device/regenerative medicine innovators indicate openness to alliance-based go-to-market strategies, enabling co-development or joint commercialization of advanced therapies and approved devices.

Geographic & Service Reach Serving national and international customers with storage, distribution, and order processing under a registered framework enables cross-border supply chain services and global distribution deals, especially for clients seeking compliant international logistics and regulatory alignment.